Scott Terrillion - Feb 29, 2024 Form 4 Insider Report for Cara Therapeutics, Inc. (CARA)

Role
SEC'Y; CHIEF COMPLIANCE & G.C.
Signature
/s/ Darren DeStefano, Attorney-in-Fact
Stock symbol
CARA
Transactions as of
Feb 29, 2024
Transactions value $
-$2,931
Form type
4
Date filed
3/4/2024, 04:24 PM
Previous filing
Feb 12, 2024
Next filing
Apr 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CARA Common Stock Sale -$2.93K -3.29K -3.49% $0.89 91K Feb 29, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person on September 7, 2018 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person.